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The hepatocarcinoma-intestine-pancreas (HIP) gene, also called pancreatitis-
associated protein-1 (PAP1) or Reg IIIα, is activated in most human hepatocellular
carcinomas (HCCs) but not in normal liver, which suggests that HIP regulatory
sequence could be used as efficient liver tumor-specific promoters to express a
therapeutic polynucleotide in liver cancer. The sodium iodide symporter (NIS), which
has recognized therapeutic and reporter gene properties, is appropriate to evaluate
the transcriptional strength and specificity of the HIP promoter in HCC. For this
purpose, we constructed a recombinant rat HIP–NIS adenoviral vector (AdrHIP-NIS),
and evaluated its performance as a mediator of selective radioiodide uptake in tumor
hepatocytes. Western blot, immunofluorescence, and iodide uptake assays were
performed in AdrHIP-NIS-infected primary hepatocytes and transformed hepatic and
nonhepatic cells. Nuclear imaging, tissue counting and immunohistochemistry were
performed in normal and HCC-bearing Wistar rats infected with AdrHIP-NIS
intratumorally or via the hepatic artery. In AdrHIP-NIS-infected transformed hepatic
cells, functional NIS was strongly expressed, as in cells infected with a
cytomegalovirus-NIS vector. No NIS expression was found in AdrHIP-NIS-infected
normal hepatocytes or transformed nonhepatic cells. In rats bearing multinodular
HCC, AdrHIP-NIS triggered functional NIS expression that was preferential in tumor
hepatocytes. Administration of 18 mCi of 131I resulted in the destruction of AdrHIP-
NIS-injected nodules. This study has identified the rHIP regulatory sequence as a
potent liver tumor-specific promoter for the transfer of therapeutic genes, and
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